Nusinersen Treatment in Spinal Muscular Atrophy Type 3: Real-life Experience from a Single Center in Türkiye (P11-11.017)

To analyze the effect of nusinersen in spinal muscular atrophy type 3 with different outcome measures.

Authors

Arman Çakar (ORCID: https://orcid.org/0000-0002-8129-4172)
Hacer Durmuş (ORCID: https://orcid.org/0000-0002-6426-676X)
Sezan Mergen Kılıç (ORCID: https://orcid.org/0000-0002-9092-6485)
Fatma Yeşim Parman

Institutions

Istanbul University (TR)

Publication Details

Journal: Neurology
Published: 2025-04-07
DOI: https://doi.org/10.1212/wnl.0000000000211140
Primary Topic: Neurogenetic and Muscular Disorders Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Nusinersen Treatment in Spinal Muscular Atrophy Type 3: Real-life Experience from a Single Center in Türkiye (P11-11.017)

Arman Çakar, Hacer Durmuş, Sezan Mergen Kılıç, Fatma Yeşim Parman

Apr 7, 2025

Neurology

Neurogenetic and Muscular Disorders Research

article

Nusinersen Treatment in Spinal Muscular Atrophy Type 3: Real-life Experience from a Single Center in Türkiye (P11-11.017)

Arman Çakar, Hacer Durmuş, Sezan Mergen Kılıç, Fatma Yeşim Parman

April 7, 2025article en

Abstract

To analyze the effect of nusinersen in spinal muscular atrophy type 3 with different outcome measures.

NeurologyVol. 104(7_Supplement_1)

Istanbul University (TR)

Zero hunger

Openalex Percentile: Top 90%

Neurogenetic and Muscular Disorders Research

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Nusinersen Treatment in Spinal Muscular Atrophy Type 3: Real-life Experience from a Single Center in Türkiye (P11-11.017) — Arman Çakar, Hacer Durmuş, et al. · Neurology (2025) | TGRS Research Map | TGRS